Page last updated: 2024-10-21

pk 11195 and Schizophrenia

pk 11195 has been researched along with Schizophrenia in 8 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.

Research Excerpts

ExcerptRelevanceReference
"Schizophrenia is a brain disease involving progressive loss of gray matter of unknown cause."1.35Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. ( Boellaard, R; Bossong, MG; Cahn, W; Caspers, E; Kahn, RS; Kloet, R; Lammertsma, AA; Luurtsema, G; Schuitemaker, A; van Berckel, BN; Windhorst, AD, 2008)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Biase, MA1
Zalesky, A1
O'keefe, G1
Laskaris, L1
Baune, BT1
Weickert, CS1
Olver, J1
McGorry, PD1
Amminger, GP1
Nelson, B1
Scott, AM1
Hickie, I1
Banati, R1
Turkheimer, F1
Yaqub, M1
Everall, IP1
Pantelis, C1
Cropley, V1
Holmes, SE1
Hinz, R1
Drake, RJ1
Gregory, CJ1
Conen, S1
Matthews, JC1
Anton-Rodriguez, JM1
Gerhard, A1
Talbot, PS1
van Berckel, BN1
Bossong, MG1
Boellaard, R1
Kloet, R1
Schuitemaker, A1
Caspers, E1
Luurtsema, G1
Windhorst, AD1
Cahn, W1
Lammertsma, AA1
Kahn, RS1
Kurumaji, A1
Wakai, T1
Toru, M1
Wodarz, N1
Rothenhöfer, C1
Fischer, R1
Stöber, G1
Kiehl, B1
Jungkunz, G1
Riederer, P1
Klein, HE1
Tanne, Z3
Weizman, R2
Karp, L3
Katz, Y1
Tyano, S3
Gavish, M3
Weizman, A1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomised Double Blind Placebo Controlled 12 Week Trial of Methotrexate Added to Treatment As Usual in Early Schizophrenia[NCT02074319]Phase 192 participants (Actual)Interventional2013-12-31Completed
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia: A Randomised Placebo-controlled Double-blind Trial[NCT02533232]Phase 160 participants (Anticipated)Interventional2022-08-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

8 other studies available for pk 11195 and Schizophrenia

ArticleYear
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.
    Translational psychiatry, 2017, 08-29, Volume: 7, Issue:8

    Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Female; Humans; Isoquinolines; Male; Microglia; Posi

2017
In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [
    Molecular psychiatry, 2016, Volume: 21, Issue:12

    Topics: Adult; Antipsychotic Agents; Brain; Female; Gyrus Cinguli; Humans; Isoquinolines; Male; Microglia; P

2016
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.
    Biological psychiatry, 2008, Nov-01, Volume: 64, Issue:9

    Topics: Adolescent; Adult; Brain Mapping; Carbon Isotopes; Case-Control Studies; Electrons; Female; Humans;

2008
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.
    Biological psychiatry, 2008, Nov-01, Volume: 64, Issue:9

    Topics: Adolescent; Adult; Brain Mapping; Carbon Isotopes; Case-Control Studies; Electrons; Female; Humans;

2008
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.
    Biological psychiatry, 2008, Nov-01, Volume: 64, Issue:9

    Topics: Adolescent; Adult; Brain Mapping; Carbon Isotopes; Case-Control Studies; Electrons; Female; Humans;

2008
Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.
    Biological psychiatry, 2008, Nov-01, Volume: 64, Issue:9

    Topics: Adolescent; Adult; Brain Mapping; Carbon Isotopes; Case-Control Studies; Electrons; Female; Humans;

2008
Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics.
    Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:11-12

    Topics: Adult; Aged; Brain; Brain Chemistry; Chronic Disease; Female; Humans; Isoquinolines; Kinetics; Male;

1997
Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients.
    Psychiatry research, 1998, Dec-14, Volume: 81, Issue:3

    Topics: Adult; Diagnosis, Differential; Female; Granulocytes; Humans; Isoquinolines; Male; Middle Aged; Psyc

1998
Lack of effect of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenics.
    Neuropsychobiology, 1987, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Blood Platelets; Female; Haloperidol; Humans; Isoquinolines; Male; Psychiatric St

1987
Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics.
    European journal of pharmacology, 1986, Feb-18, Volume: 121, Issue:2

    Topics: Adult; Antipsychotic Agents; Binding Sites; Blood Platelets; Female; Humans; Isoquinolines; Male; Re

1986
Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia.
    Life sciences, 1986, Aug-11, Volume: 39, Issue:6

    Topics: Adult; Binding Sites; Blood Platelets; Dyskinesia, Drug-Induced; Female; Humans; Isoquinolines; Male

1986